Clinical Trials Directory

Trials / Completed

CompletedNCT03630146

iPeer2Peer Program for Adolescents With Inflammatory Bowel Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
150 (actual)
Sponsor
The Hospital for Sick Children · Academic / Other
Sex
All
Age
12 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The iPeer2Peer program matches teens with Inflammatory Bowel Disease (IBD) with an older mentor who has learned to manage their IBD well and can support them emotionally and socially. This study will compare two groups of teens: those who are in the iPeer2Peer program and those in the control group (no mentor).

Detailed description

The iPeer2Peer program matches teens with Inflammatory Bowel Disease (IBD) with an older mentor who has learned to manage their IBD well and can support them emotionally and socially. This study will compare two groups of teens: those who are in the iPeer2Peer program and those in the control group (no mentor). The proposed trial aims to examine the impact of the iPeer2Peer program on self-management skills of youth with IBD (mentees) as well as health outcomes of peer mentors in the program. This innovative program leverages the Internet, commonly used by youth, to improve access and acceptability of self-management interventions while fostering social engagement in youth with IBD, thereby potentially improving HRQL.

Conditions

Interventions

TypeNameDescription
BEHAVIORALiPeer2Peer programIn addition to standard care, youth in the experimental group will receive the iPeer2Peer Program. The iPeer2Peer program is a peer mentorship program that will provide modeling and reinforcement of self-management by pre-screened and trained peer mentors (young adults with IBD aged 18-25 years) who have learned to function successfully with their disease. Mentors will encourage youth to develop and engage in disease self-management skills and provide social support.
OTHERWaitlist controlThe control group will receive standard care but without the iPeer2Peer Program.

Timeline

Start date
2018-05-17
Primary completion
2022-03-16
Completion
2022-03-16
First posted
2018-08-14
Last updated
2023-04-12

Locations

4 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT03630146. Inclusion in this directory is not an endorsement.